Glenmark Pharmaceuticals announced that its Swiss subsidiary, Glenmark Specialty S.A., would ... Separately, the company said it received marketing authorisation for an asthma drug from the Drugs Controller General of India.
Read more: Gainers & Losers: 10 stocks that moved the most on December 23